
Svastek Raises Rs 2 Cr In Seed Funding From IAN Group
SVASTEK, an innovative medtech startup addressing critical challenges in respiratory and critical care, has raised Rs 2 crore in seed funding from the IAN Angel Fund. This funding will drive the launch of SVASTEK’s flagship product, the ALLTIP technology-enabled NIV mask, and support the company’s vision to bring impactful solutions to the healthcare industry.
The funds raised will be utilised to launch the ALLTIP-enabled NIV mask across India, build a distributor network for seamless product availability, expand SVASTEK’s clinical application team to educate and train healthcare professionals and drive awareness through medical conferences and targeted outreach programs.
Padmaja Ruparel, Co-founder, IAN Group, said “SVASTEK’s revolutionary ALLTIP-enabled NIV mask, which impacts critical respiratory issues. IAN is delighted parter with the founders to build a business which will promises to bring a critical care solution to India’s healthcare industry”
With plans to expand its product portfolio and geographical footprint, the company aims to establish itself as a global leader in respiratory care, driving innovation, affordability, and accessibility in healthcare.